Location: Home
  • search
  • go
  • Relate News
  • 6/25/2021Innovent Releases Results of a Phase 1 Clinical Study of IBI362 in Ove...
  • 6/25/2021NMPA Issues the List of Reference Formulations for GQCE Studies (42nd ...
  • 6/25/2021CDE Issues the Technical Guidelines for Pharmaceutic Change Studies of...
  • 6/24/2021CStone Announces Positive GAVRETO (Pralsetinib) Registrational Study D...
  • 6/24/2021NMPA Issues the Provisions for Registration of Licensed Pharmacists
  • 6/24/2021China Concludes the 5th Round of National Level VBP, Slashing Average ...
  • 6/24/2021NMPA Revises Packages Insert of Oxiracetam Formulations and Injectable...
  • 6/24/2021CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
  • 6/24/2021Pharmaceuticals and APIs - Biden Admin Issues 100-Day Supply Chain Rev...
  • 6/23/2021Online Platform Operator Medlive Tech Advances Plans for Hong Kong IPO
  • 6/23/2021HUTCHMED's Orpathys Conditionally Approved in China for NSCLC
  • 6/23/2021Innovent's Sintilimab in Combo with Chemotherapy Meets Primary Endpoin...
  • 6/23/2021CDE Solicits Comments on the Work Procedures for Changes During Drug R...
  • 6/22/2021OPKO Health to Develop and Commercialize CKD Drug RAYALDEE in Greate...
  • 6/22/2021BeiGene Granted Chinese Conditional Approval of Zanubrutinib r/r Walde...
  • 6/22/2021Innovent's Pemazyre (pemigatinib) Approved in Taiwan
  • 6/22/2021Hutchmed Granted Chinese Approval of Surufatinib (Sulanda) for Advance...
  • 6/22/2021CDE Issues the Guide to Biological Product Change Acceptance Review (I...
  • 6/22/2021China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hep...
  • 6/22/2021China Grants First CAR-T Cell Therapy Approval to Gilead JV Fosun-Kit...
  • 6/22/2021Big Questions Remain over China's Patent Linkage System
  • 6/21/2021Preparing for China's Patent Linkage System
  • 6/21/2021AZ/MSD Granted New Indication for Lynparza (olaparib) in China
  • 6/21/2021China and U.K. Initiate Drug Regulatory Cooperation Project
  • 6/21/2021NMPA Solicits Public Comments on Two Draft Standards for Drug Tracing ...
  • 6/18/2021NMPA Issues the Requirements for Post-marketing Change Items and Appli...
  • 6/18/2021NMPA Withdraws Approvals of 42 Domestic Drug Products
  • 6/18/2021NHSA Announces Outcome of Its Inventory Survey for Drugs Included in t...
  • 6/18/2021Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance...
  • 6/18/2021FibroGen and HiFiBiO Announce Transformative Partnership to Advance Ne...
  • Page:126/719 Total number of articles:21549: [First][<<] [124] [125] [126] [127] [128] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group